Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost [PDF]
Ocular Surface, 2017 Purpose: To determine variations in cytokine levels of glaucoma patients treated either with preservative-free latanoprost or preserved latanoprost, relative to healthy individuals.
Jose M Martinez-De-La-Casa +2 more
exaly +4 more sources
Owner Obtained Intraocular Pressure Measurements in Canine Primary Angle Closure Glaucoma: A Pilot Study in 14 Dogs. [PDF]
Vet OphthalmolABSTRACT Purpose To explore the clinical value of intraocular pressure (IOP) measurements obtained by owners in dogs predisposed to primary angle closure glaucoma (PACG). Materials and Methods Owners of 14 dogs with eyes predisposed to developing PACG obtained IOP measurements with a TonoVet Plus from the time of diagnosis of PACG until they developed ...
Westermeyer HD, Salmon JH.
europepmc +2 more sources
Effects of Omidenepag Isopropyl Versus Latanoprost Eye Drops on Intraocular Pressure, Pupil Diameter, and Anterior Chamber Parameters in Normal Feline Eyes: A Pilot Study. [PDF]
Vet OphthalmolABSTRACT Objectives This study aimed to compare the effect of the newly developed selective prostaglandin E2 receptor agonist, omidenepag isopropyl (OMDI), and latanoprost on intraocular pressure (IOP), pupil diameter (PD), and anterior chamber parameters in normal feline eyes.
Park SE +5 more
europepmc +2 more sources
Developing a Chromatographic Method for Quantifying Latanoprost and Related Substances in Glaucoma Treatments [PDF]
PharmaceuticalsBackground/Objectives: Latanoprost is a leading active pharmaceutical ingredient belonging to the synthetic prostaglandin F2α analogs, widely used as a first-line treatment for open-angle glaucoma and increased intraocular pressure.
Katarzyna Asendrych-Wicik +2 more
doaj +2 more sources
Sustained intraocular pressure lowering from suprachoroidal injection of a latanoprost lipid nanoparticle delivery system in the rabbit [PDF]
Frontiers in MedicineBackgroundCurrent treatments for glaucoma to lower intraocular pressure (IOP) are dependent on patient adherence and bioavailability after bypassing ocular barriers.
Phey Feng Lo +13 more
doaj +2 more sources
Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis [PDF]
Frontiers in MedicineObjectiveTo evaluate and compare the effectiveness and safety of latanoprost, bimatoprost, travoprost, and tafluprost in lowering intraocular pressure (IOP) in individuals with glaucoma or ocular hypertension.MethodsWe searched PubMed, Embase, Web of ...
Jieting Peng, Wenrui Huang, Junguo Duan
doaj +2 more sources
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial [PDF]
International Journal of Ophthalmology, 2021 AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free (PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride (BAK)-preserved latanoprost [Xalatan®] in patients with primary open ...
Joon Mo Kim +5 more
doaj +1 more source
Latanoprost eye drops induce conjunctival lymphatic vessel development [PDF]
International Journal of Ophthalmology, 2021 AIM: To investigate the effect of latanoprost eye drops on the conjunctival lymphatics. METHODS: Twenty-four healthy New Zealand White rabbits weighing 1.5 to 2.0 kg were randomly divided into three groups: latanoprost group (n=8) administered with ...
Kai Ma +3 more
doaj +1 more source
Cosmetics, 2023 Eyelashes, in addition to fulfilling eye-protective functions, generate an aesthetic impact. Latanoprost is a prostaglandin analog, commonly used for the treatment of glaucoma and intraocular hypertension.
Janette Ivone Espinoza-Silva +3 more
doaj +1 more source
Scientific Reports, 2023 This prospective, observer-masked, randomized clinical trial was conducted between December 2018 and June 2021 at Eye Hospital, China Academy of Chinese Medical Sciences. A total of 45 glaucoma patients from Beijing, China, were enrolled in this clinical
Yipeng Shi +8 more
doaj +1 more source